ArticleEcancermedicalscience2025
Pineal gland seminoma: unusual localisation investigated through a case report and a literature review.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Germinoma (called seminoma in the testis and dysgerminoma in the ovary) is the neoplastic side of the primitive germ cell. It may be of gonadal or extragonadal origin, although intracranial location remains rare (between 0.5% and 3.2% in adults), 2/3 of which are located in the pineal region. We report a case of a patient with a seminoma of the pineal gland. Symptoms included headache, vomiting and diplopia. The work-up was negative. The patient was initially treated with bleomycin, etoposide and platinum protocol chemotherapy. The tumour was deemed inaccessible to surgery, which is why the patient underwent three-dimensional conformal radiotherapy with a dose of 24 Gy in 12 fractions to the tri-ventricular system, followed by a 16 Gy boost to the pineal region. Pineal neoplasms are rare. Its prognosis has been considerably improved thanks to a multidisciplinary approach. However, radiotherapy remains a good alternative approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.